Skip to content

Lashuna capsules in psychological complaints of menopausal ladies

An exploratory study on lashuna capsules in psychological complaints of menopausal transition

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/010204
Enrollment
30
Registered
2017-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- With menopausal symptoms

Interventions

Intervention1: Lashuna capsules: patients who will fix into the inclusion criteria will be included for study and will be given lashuna capsules for 30 days. Control Intervention1: not applicable: no

Sponsors

Dr Kavyashree K
Lead Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda Hospital Hassan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age group between 45-55years 2 Subjects under menopausal transition having irregular menstrual cycles 3 Patients who have not undergone Hormone Replacement Therapy 4 Subjects diagnosed based on above diagnostic criteria and mainly who have psychological manifestations during this phase

Exclusion criteria

Exclusion criteria: • Patients with a history of psychiatric illness and alcoholics • Patients who had surgical menopause • Patients with severe gastritis, gastric ulcer • Patients having menorrhagia • Patients having major organic pathology of reproductive system like carcinoma, fibroid cyst etc.

Design outcomes

Primary

MeasureTime frame
menopausal rating scale will be used before and after treatmentTimepoint: 30 DAYS

Secondary

MeasureTime frame
QUALITY OF LIFETimepoint: 30 DAYS

Countries

India

Contacts

Public ContactDr Savitha HP

Sri Dharmasthala Manjunatheshwara College of Ayurveda And Hospital

kavya.klm@gmail.com9481765895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026